Drug Database
Back to search

Poland· PL-100020525

Doxepin Teva

A doxepin product containing doxepinum, registered in Poland by Teva Pharmaceuticals Polska Sp. z o.o.. The same ATC class is registered in 9 of our 19 countries.

ATC N06AA12

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedDoxepin TevaATCN06AA12REGISTER NO.PL-100020525PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about doxepinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Doxepin is registered in 9 of 19 countries.

Countries holding a registration under ATC N06AA12 (doxepin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose
Search doxepin products by name

Doxepin · ATC N06AA12

9 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Germany
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Doxepinum
Manufacturer
Teva Pharmaceuticals Polska Sp. z o.o.
Country
Poland (PL)
ATC code
N06AA12
ATC class
Doxepin
Defined daily dose
0.1 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909990055012
  • gtin
    05909990422135

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

932 interactions on record for doxepin.

Graded by severity as the source publishes them — 148 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check doxepin against other medicinesHow interaction checks work

Doxepin · interactions on record

932 records

  • 148 severe
  • 527 moderate
  • 32 minor
  • 148 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe

77 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Doxepin in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All doxepin products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Germany · Doxepin Al, Doxepin Ratiopharm
  • Spain · Sinequan
  • United Kingdom (Northern Ireland) · Doxepin, Doxepin Marlborough Pharmaceuticals Ltd

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c6dbb99a-7ee3-4cba-b9c1-f91b27fc4869
GET /v1/drugs/c6dbb99a-7ee3-4cba-b9c1-f91b27fc4869?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki twarde",
  "source": "urpl",
  "strength": "25 mg",
  "packaging": "05909990055012 ¦ Rp ¦ Skasowane ¦ 3383\n30 kaps.\n05909990422135 ¦ Rp ¦ 32519\n30 kaps.",
  "substance": "Doxepini hydrochloridum 28.25 mg",
  "common_name": "Doxepinum",
  "pl_product_id": "100020525",
  "pozwolenie_nr": "00550",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about doxepin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console